Singapore markets close in 2 hours 12 minutes

Oncotelic Therapeutics, Inc. (OTLC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0382-0.0005 (-1.29%)
At close: 01:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
70
70
0
0
1,741
Operating expenses
Research development
61.143
61.143
756.91
3,659
4,302
Selling general and administrative
573.726
573.726
4,854
5,467
5,023
Total operating expenses
634.869
634.869
5,611
9,126
9,326
Operating income or loss
-564.869
-564.869
-5,611
-9,126
-7,585
Interest expense
1,045
1,045
2,971
2,003
1,998
Total other income/expenses net
-6,596
-6,596
13,258
611.406
-388.751
Income before tax
-8,206
-8,206
4,677
-10,517
-9,972
Income from continuing operations
-8,206
-8,206
4,677
-10,517
-9,972
Net income
-7,903
-7,903
5,095
-9,391
-9,503
Net income available to common shareholders
-7,903
-7,903
5,095
-9,391
-9,503
Basic EPS
-0.04
-
0.01
-0.03
-0.11
Diluted EPS
-0.04
-
0.01
-0.03
-0.11
Basic average shares
391,296
-
384,075
303,079
88,100
Diluted average shares
438,175
-
457,300
303,079
88,100